4.6 Article

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study

Related references

Note: Only part of the references are listed.
Review Oncology

Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ

Paola Clauser et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2016)

Review Oncology

Breast cancer risk associated with benign breast disease: systematic review and meta-analysis

Sara W. Dyrstad et al.

BREAST CANCER RESEARCH AND TREATMENT (2015)

Article Medicine, General & Internal

Atypical Hyperplasia of the Breast - Risk Assessment and Management Options

Lynn C. Hartmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Oncology

Estrogen Receptor Expression in Atypical Hyperplasia: Lack of Association with Breast Cancer

Emily G. Barr Fritcher et al.

CANCER PREVENTION RESEARCH (2011)

Article Oncology

Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

Marta Santisteban et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Review Oncology

Histological and biological evolution of human premalignant breast disease

DC Allred et al.

ENDOCRINE-RELATED CANCER (2001)

Article Multidisciplinary Sciences

Molecular portraits of human breast tumours

CM Perou et al.

NATURE (2000)